Tuesday, May 4, 2021

Successful Phase 3 Trial for MMDA

MAPS’ Phase 3 Trial of MDMA-Assisted Therapy for PTSD Achieves Successful Results for Patients with Severe, Chronic PTSD

No comments:

Post a Comment